FDA Clears Personalized Brain Stimulation for PTSD with High Remission Rates

The FDA has cleared a new personalized brain stimulation treatment for Post-Traumatic Stress Disorder (PTSD), developed by Wave Neuroscience. This technology uses brain mapping to guide targeted magnetic stimulation. Early clinical trial findings reported a 52% reduction in PTSD symptoms and a 68% remission rate, offering a non-medication alternative for patients unresponsive to current treatments.